Doxy-PEP keeps San Francisco at forefront of STD prevention | Health

San Francisco, a decadeslong global leader in HIV/AIDS treatment, remains on the forefront of STD prevention thanks to a pill shown to reduce the risk of spreading chlamydia, gonorrhea and syphilis.

Related Keywords

Kenya ,San Francisco ,California ,United States ,Annie Luetkemeyer ,Research On ,Foundation Strut Clinic ,Drug Administration ,Department Of Public Health ,Centers For Disease ,University Of Washington ,Oliver Bacon ,San Francisco City Clinic ,Zuckerberg San Francisco General Hospital ,Disease Control ,New England Journal ,Zuckerberg General ,Public Health ,Sexually Transmitted Diseases ,Hiv And Aids ,Csf ,